534 related articles for article (PubMed ID: 28258701)
21. Antibody targeting of B7-H4 enhances the immune response in urothelial carcinoma.
Podojil JR; Glaser AP; Baker D; Courtois ET; Fantini D; Yu Y; Eaton V; Sivajothi S; Chiang M; Das A; McLaughlin KA; Robson P; Miller SD; Meeks JJ
Oncoimmunology; 2020; 9(1):1744897. PubMed ID: 32363111
[TBL] [Abstract][Full Text] [Related]
22. The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3.
Janakiram M; Shah UA; Liu W; Zhao A; Schoenberg MP; Zang X
Immunol Rev; 2017 Mar; 276(1):26-39. PubMed ID: 28258693
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8+ T lymphocytes in human cholangiocarcinoma.
Zhao X; Guo F; Li Z; Jiang P; Deng X; Tian F; Li X; Wang S
Oncol Rep; 2016 Jul; 36(1):419-27. PubMed ID: 27177355
[TBL] [Abstract][Full Text] [Related]
24. B7-H3, B7-H4, Foxp3 and IL-2 expression in cervical cancer: Associations with patient outcome and clinical significance.
Huang C; Zhou L; Chang X; Pang X; Zhang H; Zhang S
Oncol Rep; 2016 Apr; 35(4):2183-90. PubMed ID: 26848032
[TBL] [Abstract][Full Text] [Related]
25. Isolation and Validation of Anti-B7-H4 scFvs from an Ovarian Cancer scFv Yeast-Display Library.
Dangaj D; Scholler N
Methods Mol Biol; 2015; 1319():37-49. PubMed ID: 26060068
[TBL] [Abstract][Full Text] [Related]
26. Characterization of immune regulatory molecules B7-H4 and PD-L1 in low and high grade endometrial tumors.
Bregar A; Deshpande A; Grange C; Zi T; Stall J; Hirsch H; Reeves J; Sathyanarayanan S; Growdon WB; Rueda BR
Gynecol Oncol; 2017 Jun; 145(3):446-452. PubMed ID: 28347512
[TBL] [Abstract][Full Text] [Related]
27. Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma.
Kryczek I; Wei S; Zhu G; Myers L; Mottram P; Cheng P; Chen L; Coukos G; Zou W
Cancer Res; 2007 Sep; 67(18):8900-5. PubMed ID: 17875732
[TBL] [Abstract][Full Text] [Related]
28. Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model.
Leung J; St-Onge P; Stagg J; Suh WK
Cancer Immunol Immunother; 2017 Apr; 66(4):491-502. PubMed ID: 28074226
[TBL] [Abstract][Full Text] [Related]
29. Expression of co-stimulatory molecule B7-H4 in patients suffering from rheumatoid arthritis.
Chen L; Lu Y; Wang F; Zhou M; Chu Y; Ding W; Liu C; Xie J; Wu C; Jiang J
Immunol Lett; 2013; 154(1-2):25-30. PubMed ID: 23973734
[TBL] [Abstract][Full Text] [Related]
30. Preparation and characterization of monoclonal antibody against human B7-H4 molecule.
Zhang N; Fang P; Gu ZJ
Monoclon Antib Immunodiagn Immunother; 2014 Aug; 33(4):270-4. PubMed ID: 25171007
[TBL] [Abstract][Full Text] [Related]
31. B7-H4-Ig treatment of normal mice changes lymphocyte homeostasis and increases the potential of regulatory T cells.
Kristensen NN; Schmidt EG; Rasmussen S; Balk-Møller E; Claesson MH
Immunopharmacol Immunotoxicol; 2013 Aug; 35(4):505-13. PubMed ID: 23841452
[TBL] [Abstract][Full Text] [Related]
32. B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer.
Jin Y; Zhang P; Li J; Zhao J; Liu C; Yang F; Yang D; Gao A; Lin W; Ma X; Sun Y
Int J Clin Exp Pathol; 2015; 8(11):13987-95. PubMed ID: 26823710
[TBL] [Abstract][Full Text] [Related]
33. Tim-3 and its role in regulating anti-tumor immunity.
Das M; Zhu C; Kuchroo VK
Immunol Rev; 2017 Mar; 276(1):97-111. PubMed ID: 28258697
[TBL] [Abstract][Full Text] [Related]
34. Exosomal B7-H4 from irradiated glioblastoma cells contributes to increase FoxP3 expression of differentiating Th1 cells and promotes tumor growth.
Tian Y; Liu C; Li Z; Ai M; Wang B; Du K; Liu W; Wang H; Yu P; Chen C; Lin J; Xu A; Li R; Zhang W; Yuan Y
Redox Biol; 2022 Oct; 56():102454. PubMed ID: 36044789
[TBL] [Abstract][Full Text] [Related]
35. Molecular Pathways: Evaluating the Potential for B7-H4 as an Immunoregulatory Target.
MacGregor HL; Ohashi PS
Clin Cancer Res; 2017 Jun; 23(12):2934-2941. PubMed ID: 28325750
[TBL] [Abstract][Full Text] [Related]
36. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma.
Kryczek I; Zou L; Rodriguez P; Zhu G; Wei S; Mottram P; Brumlik M; Cheng P; Curiel T; Myers L; Lackner A; Alvarez X; Ochoa A; Chen L; Zou W
J Exp Med; 2006 Apr; 203(4):871-81. PubMed ID: 16606666
[TBL] [Abstract][Full Text] [Related]
37. [Preparation of anti-B7-H4 monoclonal antibody to investigate B7-H4 expression in pancreatic cancer].
Hong B; Qian Y; Yao HP
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 42(5):511-6. PubMed ID: 24167131
[TBL] [Abstract][Full Text] [Related]
38. B7-H4 is Inversely Correlated With T-Cell Infiltration in Clear Cell but Not Serous or Endometrioid Ovarian Cancer.
Pagnotti GM; Atkinson RM; Romeiser J; Akalin A; Korman MB; Shroyer KR
Appl Immunohistochem Mol Morphol; 2019 Aug; 27(7):515-522. PubMed ID: 29189263
[TBL] [Abstract][Full Text] [Related]
39. FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy.
Ghebeh H; Barhoush E; Tulbah A; Elkum N; Al-Tweigeri T; Dermime S
BMC Cancer; 2008 Feb; 8():57. PubMed ID: 18294387
[TBL] [Abstract][Full Text] [Related]
40. Role of B7-H1 and B7-H4 molecules in down-regulating effector phase of T-cell immunity: novel cancer escaping mechanisms.
Ichikawa M; Chen L
Front Biosci; 2005 Sep; 10():2856-60. PubMed ID: 15970540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
